Major clinical trial suggests vagus nerve stimulation relieves severe depression
People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...
20 innovative breakthroughs that will transform your health
T here are always new frontiers in health care: diseases whose treatment and cures still elude us; biological and medical ...
Medindia14 天
FDA-Approved Shield for Colorectal Cancer Screening
Shield, a newly approved cell-free DNA blood-based test for cancer detection may give false positive results. This has raised a concern about improving the technique. Blood-based screening tests ...
Managed Healthcare Executive16 天
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Additional Treatment for Depression
Caplyta, an oral atypical antipsychotic taken once daily at a 42 mg dose, is currently approved for treating ... for the new application to the FDA. The patients in the studies had MDD and didn’t ...
360dx17 天
Devyser Fetal RHD Screening Test Receives IVDR Certification
The qPCR-based test is used to determine the fetal RHD status in maternal plasma starting from week 10 of pregnancy. The assay was approved for marketing in Canada in 2023. "National and regional ...
Yahoo21 天
From Hollywood-Loved LED Face Masks to Pro-Approved Microcurrent Devices, the Best Skin ...
NuFace’s Trinity+ facial toning tool is an award-winning skin-care device with innovative, interchangeable treatment attachments. Touting a “five-minute facial lift,” the FDA-cleared device ...
VietNamNet21 天
National Assembly approves ambitious anti-drug program
The National Assembly has approved a VND 22.45 trillion program aimed at eradicating drug crimes and achieving drug-free communities across Vietnam by 2030. On November 27, 453 out of 456 deputies ...
Medical Xpress22 天
FDA approves Kebilidi for aromatic L-amino acid decarboxylase deficiency
The U.S. Food and Drug Administration has approved PTC Therapeutics' Kebilidi (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...
Toronto Sun22 天
Weight-loss drug now approved in Canada to reduce risk of non-fatal heart attacks
A drug used to help Canadians lose weight has now been approved to reduce the risk of non-fatal heart attacks.
FiercePharma22 天
Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec
Twenty-three years later, patients no longer need to take a “bullet” to reap the benefits of imatinib as Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of ...
clinicaladvisor.com23 天
FDA Approves Zurnai for Emergency Treatment of Opioid Overdose
The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene ... including respiratory depression, sedation, and hypotension. The approval was supported by safety and ...
Pharmaceutical Technology23 天
Shorla Oncology’s IMKELDI approved by FDA for leukaemia cancers
IMKELDI is the first oral liquid form of imatinib for specific leukaemia cancer forms. Credit: Jo Panuwat D/Shutterstock. The US Food and Drug Administration (FDA) has approved Shorla Oncology‘s ...